Moving from Hepatitis Discovery to Elimination Series:

Collaborative Research on Hep C Identification & Treatment Among Inject Drug Users

Thursday, April 8th, 3-4:30 PM EST

Register here

Please join the National Institute of Health and National Institute on Drug Abuse (NIDA) for a webinar series on hepatitis elimination titled Moving from Hepatitis Discovery to Elimination, Research Advancing Hepatitis Elimination: Collaborative Research on Hepatitis C Identification and Treatment Among Inject Drug Users.

The series is offered on a monthly basis from March to October 2021.

Research projects to be presented:

“The Kentucky Viral Hepatitis Treatment Study (KeY Treat)”
-Dr. Jennifer Havens, Professor, College of Medicine, Center on Drug and Alcohol Research, University of Kentucky

“Impact of HCV treatment in HIV/HCV co-infected and mono-infected
incarcerated persons”
-Dr. Risha Irvin, Assistant Professor, School of Medicine, John Hopkins University

“HIV, HCV and Related Comorbidities in Rural Communities Affected by
Opioid Injection Drug Epidemics in the United States: Building Systems
for Prevention, Treatment and Control”
-Todd M. Allen, Professor of Medicine, Harvard Medical School, Ragon Institute of MGH, MIT and Harvard, Massachusetts General Hospital